The Involvement of Circulating Microparticles in Inflammation, Coagulation and Cardiovascular Diseases

Overview

Journal Can J Cardiol

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2010 Apr 14

PMID 20386775

Citations 73

Authors

Paolo Puddu

Giovanni M Puddu

Eleonora Cravero

Silvia Muscari

Antonio Muscari

Affiliations

Soon will be listed here.

Abstract

Microparticles (MPs) are small vesicles, ranging in size from 0.1 microm to 2 microm, originating from plasma membranes of endothelial cells, platelets, leukocytes and erythrocytes. MPs can transfer antigens and receptors to cell types that are different from their cell of origin. Circulating MPs provide a procoagulant aminophospholipid surface for the assembly of the specific enzymes of coagulation. Both tissue factor and phosphatidylserine are exposed on MP outer membranes. In addition, MPs can play a significant role in vascular function and inflammation by modulating nitric oxide and prostacyclin production in endothelial cells, and stimulating cytokine release and tissue factor induction in endothelial cells, as well as monocyte chemotaxis and adherence to the endothelium. Finally, increased levels of MPs have been found in the presence of acute coronary syndromes, ischemic stroke, diabetes, systemic and pulmonary hypertension, and hypertriglyceridemia. From a practical point of view, MPs could be considered to be important markers of cardiovascular risk, as well as surrogate end points for assessing the efficacy of new drugs and therapies.

Citing Articles

The Microbiota-Gut-Brain Axis: Key Mechanisms Driving Glymphopathy and Cerebral Small Vessel Disease.

Che Mohd Nassir C, Che Ramli M, Ghazali M, Jaffer U, Abdul Hamid H, Mehat M Life (Basel). 2025; 15(1).

PMID: 39859943 PMC: 11766513. DOI: 10.3390/life15010003.

Reversible Cerebral Vasoconstriction Syndrome Following Blood Transfusion in a Patient With Chronic Anemia: A Case Report.

Verma A, Sharma G, Singh A, Gupta H, Singh D, Gaidhane A Clin Case Rep. 2024; 12(12):e9618.

PMID: 39610984 PMC: 11602260. DOI: 10.1002/ccr3.9618.

Inpatient outcomes of NSTEMI among patients with immune thrombocytopenia: a propensity matched national study.

Ali Baig M, Chaliki K Ann Hematol. 2024; 103(9):3443-3451.

PMID: 39096370 DOI: 10.1007/s00277-024-05913-7.

Extracellular Vesicles in Malaria: Shedding Light on Pathogenic Depths.

Dey S, Mohapatra S, Khokhar M, Hassan S, Pandey R ACS Infect Dis. 2024; 10(3):827-844.

PMID: 38320272 PMC: 10928723. DOI: 10.1021/acsinfecdis.3c00649.

Delivery of Growth Factors to Enhance Bone Repair.

Ball J, Shelby T, Hernandez F, Mayfield C, Lieberman J Bioengineering (Basel). 2023; 10(11).

PMID: 38002376 PMC: 10669014. DOI: 10.3390/bioengineering10111252.

References

Williams J, Jauch E, Lindsell C, Campos B . Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis. Acad Emerg Med. 2007; 14(8):685-90. DOI: 10.1197/j.aem.2007.04.009. View

Combes V, Simon A, Grau G, Arnoux D, Camoin L, Sabatier F . In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999; 104(1):93-102. PMC: 408397. DOI: 10.1172/JCI4985. View

Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A . Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?. J Thromb Haemost. 2008; 7(1):190-7. DOI: 10.1111/j.1538-7836.2008.03200.x. View

Amabile N, Guerin A, Leroyer A, Mallat Z, Nguyen C, Boddaert J . Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005; 16(11):3381-8. DOI: 10.1681/ASN.2005050535. View

Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S, Iwasaka T . Losartan and simvastatin inhibit platelet activation in hypertensive patients. J Thromb Thrombolysis. 2005; 18(3):177-85. DOI: 10.1007/s11239-005-0343-8. View

ZWAAL R, Schroit A . Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997; 89(4):1121-32. View

Shouzu A, Nomura S, Omoto S, Hayakawa T, Nishikawa M, Iwasaka T . Effect of ticlopidine on monocyte-derived microparticles and activated platelet markers in diabetes mellitus. Clin Appl Thromb Hemost. 2004; 10(2):167-73. DOI: 10.1177/107602960401000207. View

Ahn Y, Jy W, Jimenez J, Horstman L . More on: cellular microparticles: what are they bad or good for?. J Thromb Haemost. 2004; 2(7):1215-6. DOI: 10.1111/j.1538-7836.2004.00797.x. View

Meziani F, Tesse A, Andriantsitohaina R . Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Pharmacol Rep. 2008; 60(1):75-84. View

10.

Agouni A, Lagrue-Lak-Hal A, Ducluzeau P, Mostefai H, Draunet-Busson C, Leftheriotis G . Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol. 2008; 173(4):1210-9. PMC: 2543087. DOI: 10.2353/ajpath.2008.080228. View

11.

Nomura S, Shouzu A, Omoto S, Hayakawa T, Kagawa H, Nishikawa M . Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thromb Haemost. 1998; 80(3):388-92. View

12.

Brodsky S, Zhang F, Nasjletti A, Goligorsky M . Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004; 286(5):H1910-5. DOI: 10.1152/ajpheart.01172.2003. View

13.

Patel K, Zimmerman G, Prescott S, McIntyre T . Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J Biol Chem. 1992; 267(21):15168-75. View

14.

Kusterer K, Pohl T, FORTMEYER H, Marz W, Scharnagl H, Oldenburg A . Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilatation in rats. Cardiovasc Res. 1999; 42(3):783-93. DOI: 10.1016/s0008-6363(98)00331-9. View

15.

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

16.

Mause S, von Hundelshausen P, Zernecke A, Koenen R, Weber C . Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol. 2005; 25(7):1512-8. DOI: 10.1161/01.ATV.0000170133.43608.37. View

17.

Morel O, Toti F, Hugel B, Freyssinet J . Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol. 2004; 11(3):156-64. DOI: 10.1097/01.moh.0000131441.10020.87. View

18.

Barry O, Pratico D, Lawson J, FitzGerald G . Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 1997; 99(9):2118-27. PMC: 508042. DOI: 10.1172/JCI119385. View

19.

Goto S, Tamura N, Li M, Handa M, Ikeda Y, Handa S . Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. J Thromb Haemost. 2003; 1(9):2022-30. DOI: 10.1046/j.1538-7836.2003.00349.x. View

20.

Lal S, Brown A, Nguyen L, Braet F, Dyer W, Dos Remedios C . Using antibody arrays to detect microparticles from acute coronary syndrome patients based on cluster of differentiation (CD) antigen expression. Mol Cell Proteomics. 2008; 8(4):799-804. PMC: 2667358. DOI: 10.1074/mcp.M800335-MCP200. View